MONROVIA, Calif., Sept. 19 /PRNewswire-FirstCall/ -- STAAR Surgical Company , a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today announced a change to its presentation time at the UBS Global Life Sciences Conference. The presentation will now take place at 12:30 PM Eastern Time at the Grand Hyatt in New York City on Thursday, September 28th, 2006. The Company was originally scheduled to present at 12:00 PM Eastern Time.
Attendance at the conference is by invitation only. A live audio-only webcast of STAAR's presentation may be accessed through the Company's website at http://www.staar.com/ . An archived replay of the presentation will be available approximately 3 hours after the live presentation and can also be accessed at http://www.staar.com/ .
About STAAR Surgical
STAAR Surgical is a leader in the development, manufacture and marketing of minimally invasive ophthalmic products employing proprietary technologies. STAAR's products are used by ophthalmic surgeons and include the Visian ICL, a tiny, flexible lens implanted to correct refractive errors, as well as innovative products designed to improve patient outcomes for cataracts and glaucoma. STAAR's ICL is approved by the FDA for use in treating myopia, has received CE Marking and is approved for sale in 43 countries. More than 50,000 ICLs have been sold worldwide. More information is available at http://www.staar.com/ .
CONTACT: Investors Media
EVC Group EVC Group
Douglas Sherk, 415-896-6820 Jen Saunders, 646-277-8720
Jennifer Beugelmans, 646-277-8704
